← Leaderboards
Frank I Tarazi
Biostream Therapeutics, Inc.
$1,300,040
Attributed
$1,300,040
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $241.5K · FY2005–08$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,300,040 · 5
By mechanism
R21$438,725 · 1
R41$398,903 · 2
R43$301,412 · 1
R03$161,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Biostream Therapeutics, Inc.
Same institution · by research overlap
- Miles P Smith$383,922
- Monika M Trzcinska$107,344
- Srihari R Tella$161,496
Others in their field
Top investigators on “Laboratory Rat”
- Barney Sparrow · Battelle Memorial Institute$68,853,027
- Richard A Gibbs · Baylor College Of Medicine$59,652,654
- Howard J Jacob · Medical College Of Wisconsin$35,611,302
- David Heimbrook · Leidos Biomedical Research, Inc.$26,424,278
- Milton D Hejtmancik · Battelle Centers/Pub Hlth Res & Evaluatn$24,972,057
- Charles Hebert · Southern Research Institute$24,146,988
Research focus
Laboratory RatDrug Design /Synthesis /ProductionSerotonin ReceptorNonhuman Therapy EvaluationDrug Screening /EvaluationNeuropharmacologyAmphetaminesPharmacokineticsDisease /Disorder ModelAdrenergicAttentionAffinityAttention Deficit DisorderAttention Deficit Hyperactivity DisorderDopamine TransporterDoseDopamineAdverse EffectsBehavior TestAdolescentAnimalsDopamine D4 ReceptorBehavioral ParadigmBehavioral
Grant awards (7)
Hybrid Drugs: Novel Pharmacotherapy for ADHD$197,225
R21 · FY2008 · HD · contact PI
Hybrid Drugs: Novel Pharmacotherapy for ADHD$241,500
R21 · FY2007 · HD · contact PI
Effects of antipsychotic drugs on brain and behavior$80,500
R03 · FY2005 · MH
Norepinephrine Transporters: Targets for ADHD$301,412
R43 · FY2004 · HD
Effects of antipsychotic drugs on brain and behavior$80,500
R03 · FY2004 · MH
Novel pharmacotherapies for treatment of ADHD$295,466
R41 · FY2003 · HD
Neuroadaptive effects after chronic CTDP 31446 treatment$103,437
R41 · FY2001 · DA